This is because the inhibition of LRP1 receptor–CXCR3-A binding leads to reduced CXCR3-A internalization, which supports our hypothesis that upregulation of LRP1 in the tumor may have the opposite effect, promoting CXCR3-A endocytosis and reducing GBM invasion (Fig. 3). This evidence concerns the gene LRP1 and neoplasm.